Table 1.
The diagnostic accuracy of different AD testing modalities.
| Study | Sensitivity (%) | Specificity (%) |
|---|---|---|
| Imaging | ||
| X-ray | ||
| Lovy 2013 [65] | 78.8 | 82.5 |
| Funakoshi 2018 [69] | 81 | 89 |
| Helical CT | ||
| Shiga 2006 [70] | 100 | 98 |
| MDCT | ||
| Mishra 2005 [71] | 100 | 100 |
| MRI | ||
| Shiga 2006 [70] | 98 | 98 |
| TEE | ||
| Shiga 2006 [70] | 98 | 95 |
| Pepi 2000 [72] | 100 | 100 |
| Biochemical Measurements | ||
| sELAF | ||
| Shinohara 2003 [73] | - | 99.8 |
| smMHC | ||
| Suzuki 2000 [74] | 90.9 | 98 |
| D-Dimer | ||
| Watanabe 2016 [75] | 95.2 | 60.4 |
| Li 2017 [76] | 94 | 56.8 |
| Nazerian 2017 [77] | 96.7 | 64 |
| Itagaki 2018 [78] | 98.9 | - |
| Matrix Metalloproteinase 8 (MMP8) | ||
| Giachino 2013 [79] | 100 | 9.5 |
| Matrix Metalloproteinase 9 (MMP9) | ||
| Giachino 2013 [79] | 96.2 | 16.2 |
| Li 2018 [79] | 68.2 | 84.1 |
| MiRNA 15a | ||
| Dong 2017 [80] | 75.7 | 82.5 |
| ST2 | ||
| Wang 2018 [81] | 99.1 | 84.9 |
| Morello 2020 [82] | 95.5 | 85.1 |